Levitee Labs Stock Price, News & Analysis
Company Description
Levitee Labs (OTC Link: LVTTF) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $369.2K.
LVTTF stock has declined 100.0% over the past year.
This page provides a comprehensive overview of LVTTF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Levitee Labs (LVTTF) stock. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $369.2K, LVTTF is classified as a micro-cap stock with approximately 80.1M shares outstanding.
Latest News
Levitee Labs has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include private placement, partnership, management, acquisition. View all LVTTF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
LVTTF Company Profile & Sector Positioning
Levitee Labs (LVTTF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing LVTTF often look at related companies in the same sector, including CuraScientific copr (CSTF), Livewire (LVVV), Digicann Ventures Inc. (AGFAF), Global Hemp Group Inc (GBHPF), and Greater Cannabis (GCAN). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate LVTTF's relative position within its industry.